These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30974078)
1. Can the Microbiome Deliver? A Proof-of-Concept Engineered E. coli PKU Therapeutic. Alteri CJ Cell Host Microbe; 2019 Apr; 25(4):473-474. PubMed ID: 30974078 [TBL] [Abstract][Full Text] [Related]
2. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Isabella VM; Ha BN; Castillo MJ; Lubkowicz DJ; Rowe SE; Millet YA; Anderson CL; Li N; Fisher AB; West KA; Reeder PJ; Momin MM; Bergeron CG; Guilmain SE; Miller PF; Kurtz CB; Falb D Nat Biotechnol; 2018 Oct; 36(9):857-864. PubMed ID: 30102294 [TBL] [Abstract][Full Text] [Related]
3. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice. van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009 [TBL] [Abstract][Full Text] [Related]
4. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study. Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792 [TBL] [Abstract][Full Text] [Related]
5. Alternative therapies to address the unmet medical needs of patients with phenylketonuria. Blau N; Longo N Expert Opin Pharmacother; 2015 Apr; 16(6):791-800. PubMed ID: 25660215 [TBL] [Abstract][Full Text] [Related]
6. Behaviour and school achievement in patients with early and continuously treated phenylketonuria. Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330 [TBL] [Abstract][Full Text] [Related]
7. Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer. Oh HJ; Park ES; Kang S; Jo I; Jung SC Pediatr Res; 2004 Aug; 56(2):278-84. PubMed ID: 15181195 [TBL] [Abstract][Full Text] [Related]
8. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes? Stevenson M; McNaughton N Brain Res Bull; 2013 Oct; 99():63-83. PubMed ID: 24140048 [TBL] [Abstract][Full Text] [Related]
9. Phenylketonuria Diet Promotes Shifts in Firmicutes Populations. Bassanini G; Ceccarani C; Borgo F; Severgnini M; Rovelli V; Morace G; Verduci E; Borghi E Front Cell Infect Microbiol; 2019; 9():101. PubMed ID: 31058098 [TBL] [Abstract][Full Text] [Related]
10. Optimal serum phenylalanine for adult patients with phenylketonuria. Okano Y; Nagasaka H Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552 [TBL] [Abstract][Full Text] [Related]
11. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria. Ratzmann GW; Grimm U; Jährig K; Knapp A Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755 [TBL] [Abstract][Full Text] [Related]
12. Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaire. Jurecki E; Cunningham A; Birardi V; Gagol G; Acquadro C Health Qual Life Outcomes; 2017 Mar; 15(1):46. PubMed ID: 28274259 [TBL] [Abstract][Full Text] [Related]
13. The incidence of phenylketonuria in Thailand. Kietduriyakul V; Komkris V; Tongkittikul K; Leangphibul P J Med Assoc Thai; 1989 Sep; 72(9):516-9. PubMed ID: 2809457 [TBL] [Abstract][Full Text] [Related]
14. Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria. Antoshechkin AG; Chentsova TV; Tatur VYu ; Naritsin DB; Railian GP J Inherit Metab Dis; 1991; 14(5):749-54. PubMed ID: 1779620 [TBL] [Abstract][Full Text] [Related]
15. Sapropterin dihydrochloride: a new drug and a new concept in the management of phenylketonuria. Trefz FK; Belanger-Quintana A Drugs Today (Barc); 2010 Aug; 46(8):589-600. PubMed ID: 20830319 [TBL] [Abstract][Full Text] [Related]
16. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU). Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376 [TBL] [Abstract][Full Text] [Related]
17. Optimising growth in phenylketonuria: current state of the clinical evidence base. Dokoupil K; Gokmen-Ozel H; Lammardo AM; Motzfeldt K; Robert M; Rocha JC; van Rijn M; Ahring K; Bélanger-Quintana A; MacDonald A Clin Nutr; 2012 Feb; 31(1):16-21. PubMed ID: 21959353 [TBL] [Abstract][Full Text] [Related]